Our Vision

Statement of strategic intent

At Medefer, we want to be the world’s most patient-focused virtual health service.

We are on a mission to help patients get better faster.

We are partnering with the NHS to build the best outpatient process, helping assess patients more quickly.

To do this work with our partners, we provide technology-enabled clinical and operational expertise, making it better for patients, healthcare professionals and the NHS.

We live by our values

Patient-first
We are determined to deliver an unrivalled healthcare experience for every patient.

Collaborative
We hold a deep-held commitment to creating enabling shared solutions and partnerships for the benefit of all.

Inventive
We challenge conventional thinking and continuously improve our solutions.


Our People

Executive and Senior Management

Dr Bahman Nedjat-Shokouhi

Founder & CEO

Bahman is the founder and Chief Executive Officer of Medefer.

With a deep commitment to patient care and the NHS, Bahman’s vision is to completely transform the way that healthcare is delivered by providing patients with the best – timely, efficient and effective – healthcare experience possible.

The considerable potential for Medefer to develop transformative solutions beyond the current scope of activity is a key driver for Bahman in developing and extending his vision to a broader range of transformative healthcare solutions – with a focus on patient safety and increasing organisational efficiency.

With a Medical Degree from University College London, an intercalated BSc in Neuroscience and a PhD in Molecular Biology and Immunology, Bahman continues to practice as Consultant Gastroenterologist at Whittington Hospital NHS Trust – maintaining his commitment to, and connections within, the NHS. Bahman has also developed educational programmes for international audiences and published papers in leading journals on his work in the NHS and with Medefer.

Dr Ed Bosonnet

Medical Director for Primary Care

Ed joined Medefer in 2016 bringing his passion for innovation to the team.

Ed qualified as a GP in 2002. With experience in leadership roles in the NHS and as a Member of a Clinical Commissioning Group (CCG) governing body, Ed developed an interest in the potential for innovation in IT to drive both strategy and healthcare delivery. He represented the CCG as its Clinical Quality Lead for the Royal Free Hospital NHS Foundation Trust and developed an interest in IT service development and strategy, becoming the CCG’s Clinical IT Lead.

At Medefer, Ed continues to develop innovative virtual healthcare strategies. He engages with CCGs and primary care  to identify opportunities to support and  extend the reach of Medefer’s unique virtual solutions within the NHS.

Dr Matthew Knight MBE

Medical Director

Matthew is Medefer’s Clinical Lead for Respiratory and was made Deputy Medical Director in September 2020.

Matthew was Associate Postgraduate Dean for Medicine at the postgraduate school of Medicine based at Health Education East of England in Cambridge (2017-20) and was the head of department of respiratory medicine at West Hertfordshire Hospitals NHS Trust.

He was the Royal College Tutor for Medicine at West Hertfordshire Hospitals Trust from 2016 to 2020. During the Coronavirus outbreak of 2020 he established and led the COVID Virtual hospital in Hertfordshire.

Matthew has a clinical interest in chronic cough, unexplained breathlessness, cardio-pulmonary exercise testing and upper airway allergy. He has been actively involved in research into emergency pleural disease management and out of hospital care for acute respiratory conditions.

Matthew was awarded an MBE in the Queen’s Birthday Honours List of 2020 for his services to healthcare, in particular for his work with COVID-19.

Megan Grant

Chief Operating Officer

Megan has over 15 years of operational leadership experience of delivering Workforce Management and Recruitment services to the NHS.

Megan is skilled at working with multi-disciplinary teams, designing and delivering high volume, scalable, customer-centric services that are desirable, feasible and viable, using innovative and pragmatic solutions.

“After spending so many years helping to try and solve workforce issues in the NHS, it is incredibly exciting to be working at Medefer, designing and implementing services that transform the model of patient care and not only help to improve health outcomes and patient experience but also alleviate and resolve a number of workforce challenges.” 

Martin Smith

Chief Financial Officer

Martin qualified as a Chartered Accountant before spending more than a decade working in Investment Banking, advising small and mid-cap companies on growth strategies, debt and equity fundraising and mergers and acquisitions. His clients included a number in the Healthcare Sector serving the NHS.

He then moved to Monitor, the independent financial regulator for the NHS where he led the approach to mergers and acquisitions in the NHS. As a Senior Director, he also led multi-disciplinary teams in financial turnaround and other complex situations.

Shelley Garlington

Business Development Director

Shelley has more than 25 years of hands-on health and care experience, going all the way back to her time as a nurse. She helps match ideas, products and services to what the sector needs by drawing on commercial skills developed in the private and public sector. By building the right kind of partnerships and empathy to understand what everyone needs she focuses on better outcomes for patients and better value for the NHS.

‘As a former nurse, patient care and quality outcomes are at the heart of all I do, as such I am thrilled to be part of the national solution to building capacity in elective care as we recover from the effects of the global pandemic. Medefer’s offer builds on all the experiences we have gained in the last year and enables our people to get the care they need faster.’

Tony Boness

Director of Service Delivery

Tony has a wealth of experience gained in strategic and operational roles within NHS Trusts. Having started his professional healthcare career through the NHS graduate scheme, Tony has since been instrumental in delivering numerous large scale change programmes across the NHS. His passion however is for delivering outstanding clinical services underpinned by an ethos of continuous improvement.

In Tony’s most recent Director position at an ‘Outstanding’ Acute Trust, he was proud to hold leadership accountability for eight diverse clinical services ranging from Cancer and Oncology to Pathology and Elective Access & Outpatient services. He is known as a versatile, progressive and competent operational Director with an empathetic and collaborative approach.

‘As the NHS faces one of its greatest challenges since its inception, I just knew it was the perfect time to join Medefer.  I’m looking forward to using my skills and expertise to deliver an exceptional outpatient service that is fit for the 21st century and to help establish Medefer as a long-term partner of the NHS.’

Board

Bruce Bower

Non-Executive Director

Bruce is a private investor based in London, with interests in technology, health and media.  He is a non-executive director of Medefer, Support Room, and Life & Soul Pictures. He helps early-stage companies with strategy, finance and fundraising.  Previously, he was a Portfolio Manager and a Partner at Verno Capital, a Russia-focused investment fund with a peak of $5 billion under management or advisory.  He began his career at Citigroup as a proprietary trader in the FX and Rates division.

Bruce is the author of “Peak Performance of Trading and Investing”.  He holds a BA from the University of Chicago and a MSc from the London School of Economics.

He has been involved with Medefer since the beginning. He loves that the company is addressing a huge unmet need for society with an innovative technological solution.

Saav Shah

Non-Executive Director

Saav is a partner at Nickleby Capital, an investment house backed by family offices and entrepreneurs.

Prior to joining Nickleby Capital, Saav ran the co-investment division of Chrystal Capital.

He advised a small group of family offices and UHNWIs, investing between £2-£15m into European private equity opportunities including Neo4J, MotoCaddy, Docplanner, Coople, Le Tote and Candid.

Saav began his career in the investment banking divisions of Rothschild, Goldman Sachs and Commerzbank.

Avril Millar

Non-Executive Director

Originally a Civil Engineer, Avril then taught Oxbridge entrance Physics and Maths for several years while her children were small before, in 1986, starting a boutique Wealth Planning business, which focussed on entrepreneurs, building it to over £500m under advice before exiting in 2007. At her exit, a client asked Avril to take over as CEO of his global banking headhunting firm, where she subsequently managed its turnaround after the 2008 crisis. Since 2009, Avril has held a number of simultaneous advisory, Non-Exec, and Interim Executive roles, typically involving businesses in high growth phases which need upskilling of the Board and senior team. Sector neutral, the businesses advised on or worked with include physical oil trading, healthcare (IVF and `resuscitation training), FX trading, deep technology, data security, investments, research, and sports. Strongly commercial, Avril specialises in helping businesses and teams grow from good to great.

‘At this stage of my long career, purpose and meaning are paramount. I am exceptionally proud and thrilled to be asked to help Medefer and its team of committed people achieve its mission to transform healthcare, support the NHS, and improve the quality of life for patients.’

Russell Wilcox

Senior Independent Director

Advisory Board

Professor Sir Mike Richards

Professor Sir Mike Richards was a hospital physician for more than 20 years. After a variety of training posts, he was a consultant medical oncologist between 1986 and 1995, and Professor of Palliative Medicine at Guy’s and St. Thomas’ Hospitals between 1995 and 1999.

In 1999 Sir Mike was appointed as the first National Cancer Director at the Department of Health. He led the development and implementation of the NHS Cancer Plan in 2000, the Cancer Reform Strategy in 2007 and Improving Outcomes: A strategy for cancer in 2011.

He became CQC’s first Chief Inspector of Hospitals in July 2013 and led the development and implementation of a new approach to hospital inspection. Sir Mike retired from this role at the end of July 2017.

Sir Mike was awarded a CBE in 2001 and appointed a Knight Bachelor in 2010

He has recently led two major reviews for NHS England: A review of adult screening services (published 2019) and a review of diagnostic services (published October 2020). This recommends a major expansion of diagnostic capacity and a new model of service delivery.

“Medefer has the potential to transform pathways to diagnosis for a very large number of patients, thereby improving patient experience and clinical outcomes.  I am delighted to be a member of the Clinical advisory Group.”

Sir Cyril Chantler

Cyril Chantler was Professor of Paediatric Nephrology and Consultant Paediatrician at Guys Hospital until 2000. He was Principal of Guy’s and St Thomas’s Hospitals Medical and Dental Schools(1992 – 1998) and Chairman of the management board of Guy’s Hospital (1985-1988). He was Chairman of Great Ormond Street Hospital (2001- 2008) and the Kings Fund (2004-2010), 

He received a knighthood for services to medicine in 1996. In January 2017 he was made a Knight Grand Cross of the Order of the British Empire (GBE) for Services to Leadership in Healthcare.

In addition, he served as a member of the Member of the NHS Policy Board (1989-1996), President of the British Association of Medical Managers (1991-1997), and as Chairman of the Council of Heads of UK Medical Schools and Faculties (1998 –1999). He was also a Member of the General Medical Council (1994–2003), where he was Chairman of the Standards Committee. He served for some years as an adviser to the Hospital Authority of Hong Kong and co-chaired the SARS expert advisory enquiry in 2003.His other previous appointments include non-executive Director of the Guy’s/Lewisham Trust (1991-92) and of the Guy’s and St Thomas’ NHS Trust (1993-97).  In addition he was Pro-Vice Chancellor, University of London (1997-2000). He was co-editor of Paediatric Nephrology from 1985 to 1996.  He served as a Member of the Council of St. George’s Medical School (2000–2003) and of the Board of Governors of London South Bank University (2002-2005).  He was Medical Director of Well Child (2001-2005), a trustee of the Dunhill Medical Trust (2001-2009) and of the British Kidney Patients Association (2007-2010). He served as Chairman of the Strategic Advisory Group for the development of Dulwich Community Hospital (2000-2005). He was Chairman of the Shared Medical Record Committee of the Care Record Development Board of Connecting for Health, and has also been involved in a number of inquiries into the provision of acute paediatric services in various parts of England. 

He was elected as an Honorary Member of the American Paediatric Society in 1991 and as a Foreign Associate of the National Academy of Medicine USA in 1999.  Cyril Chantler is a Fellow of Kings College, London, an Honorary Fellow of the Institute of Child Health London, and received an Honorary Fellowship of the Royal College of Surgeons of England in 2018 and the Royal College of Obstetricians and Gynaecologists in 2019. He has honorary degrees from London South Bank University, the University of Lille, France, the University of London, the University of Kent and University College London. He was awarded the James Spence Medal of the Royal College of Paediatrics and Child Health in 2005 and the Ira Greifer Award of the International Pediatric Nephrology Association in 2007. In 2015 he was awarded the Otto Wolff Medal by the Royal Society of Medicine. 

Sir David Dalton

Sir David has been an NHS Chief Executive for 25 years, serving at Salford Royal for 17+ years – rated ‘outstanding’ by the Care Quality Commission in each consecutive year and designated as a Global Digital Exemplar, following the creation of one of first integrated digital care records in the NHS.

He led the Northern Care Alliance, creating 5 new integrated Care Organisations in Greater Manchester.  He has a particular interest in supporting improvement and empowering staff – with a focus on patient safety.  He produced the first Quality Improvement Strategy for an NHS Trust with an explicit aim of saving lives and reducing harm.

He was knighted in 2014 for his services to Healthcare. He was a member of the ‘Berwick Review’, which advised the government on patient safety improvements and co-chaired a national review to support openness in reporting harmful events. In 2014 he led the Dalton Review which recommended actions to assure high quality healthcare was delivered through sustainable NHS organisations.

“Medefer provides the missing piece for the NHS in its search for a partner to deliver better healthcare, quicker and more reliably than it can do on its own.”

Our People

Executive and Senior Management

Dr Bahman Nedjat-Shokouhi

Founder & CEO

Bahman is the founder and Chief Executive Officer of Medefer.

With a deep commitment to patient care and the NHS, Bahman’s vision is to completely transform the way that healthcare is delivered by providing patients with the best – timely, efficient and effective – healthcare experience possible.

The considerable potential for Medefer to develop transformative solutions beyond the current scope of activity is a key driver for Bahman in developing and extending his vision to a broader range of transformative healthcare solutions – with a focus on patient safety and increasing organisational efficiency.

With a Medical Degree from University College London, an intercalated BSc in Neuroscience and a PhD in Molecular Biology and Immunology, Bahman continues to practice as Consultant Gastroenterologist at Whittington Hospital NHS Trust – maintaining his commitment to, and connections within, the NHS. Bahman has also developed educational programmes for international audiences and published papers in leading journals on his work in the NHS and with Medefer.

Dr Ed Bosonnet

Medical Director for Primary Care

Ed joined Medefer in 2016 bringing his passion for innovation to the team.

Ed qualified as a GP in 2002. With experience in leadership roles in the NHS and as a Member of a Clinical Commissioning Group (CCG) governing body, Ed developed an interest in the potential for innovation in IT to drive both strategy and healthcare delivery. He represented the CCG as its Clinical Quality Lead for the Royal Free Hospital NHS Foundation Trust and developed an interest in IT service development and strategy, becoming the CCG’s Clinical IT Lead.

At Medefer, Ed continues to develop innovative virtual healthcare strategies. He engages with CCGs and primary care  to identify opportunities to support and  extend the reach of Medefer’s unique virtual solutions within the NHS.

Dr Matthew Knight MBE

Medical Director

Matthew is Medefer’s Clinical Lead for Respiratory and was made Deputy Medical Director in September 2020.

Matthew was Associate Postgraduate Dean for Medicine at the postgraduate school of Medicine based at Health Education East of England in Cambridge (2017-20) and was the head of department of respiratory medicine at West Hertfordshire Hospitals NHS Trust.

He was the Royal College Tutor for Medicine at West Hertfordshire Hospitals Trust from 2016 to 2020. During the Coronavirus outbreak of 2020 he established and led the COVID Virtual hospital in Hertfordshire.

Matthew has a clinical interest in chronic cough, unexplained breathlessness, cardio-pulmonary exercise testing and upper airway allergy. He has been actively involved in research into emergency pleural disease management and out of hospital care for acute respiratory conditions.

Matthew was awarded an MBE in the Queen’s Birthday Honours List of 2020 for his services to healthcare, in particular for his work with COVID-19.

Megan Grant

Chief Operating Officer

Megan has over 15 years of operational leadership experience of delivering Workforce Management and Recruitment services to the NHS.

Megan is skilled at working with multi-disciplinary teams, designing and delivering high volume, scalable, customer-centric services that are desirable, feasible and viable, using innovative and pragmatic solutions.

“After spending so many years helping to try and solve workforce issues in the NHS, it is incredibly exciting to be working at Medefer, designing and implementing services that transform the model of patient care and not only help to improve health outcomes and patient experience but also alleviate and resolve a number of workforce challenges.” 

Martin Smith

Chief Financial Officer

Martin qualified as a Chartered Accountant before spending more than a decade working in Investment Banking, advising small and mid-cap companies on growth strategies, debt and equity fundraising and mergers and acquisitions. His clients included a number in the Healthcare Sector serving the NHS.

He then moved to Monitor, the independent financial regulator for the NHS where he led the approach to mergers and acquisitions in the NHS. As a Senior Director, he also led multi-disciplinary teams in financial turnaround and other complex situations.

Shelley Garlington

Business Development Director

Shelley has more than 25 years of hands-on health and care experience, going all the way back to her time as a nurse. She helps match ideas, products and services to what the sector needs by drawing on commercial skills developed in the private and public sector. By building the right kind of partnerships and empathy to understand what everyone needs she focuses on better outcomes for patients and better value for the NHS.

‘As a former nurse, patient care and quality outcomes are at the heart of all I do, as such I am thrilled to be part of the national solution to building capacity in elective care as we recover from the effects of the global pandemic. Medefer’s offer builds on all the experiences we have gained in the last year and enables our people to get the care they need faster.’

Tony Boness

Director of Service Delivery

Tony has a wealth of experience gained in strategic and operational roles within NHS Trusts. Having started his professional healthcare career through the NHS graduate scheme, Tony has since been instrumental in delivering numerous large scale change programmes across the NHS. His passion however is for delivering outstanding clinical services underpinned by an ethos of continuous improvement.

In Tony’s most recent Director position at an ‘Outstanding’ Acute Trust, he was proud to hold leadership accountability for eight diverse clinical services ranging from Cancer and Oncology to Pathology and Elective Access & Outpatient services. He is known as a versatile, progressive and competent operational Director with an empathetic and collaborative approach.

‘As the NHS faces one of its greatest challenges since its inception, I just knew it was the perfect time to join Medefer.  I’m looking forward to using my skills and expertise to deliver an exceptional outpatient service that is fit for the 21st century and to help establish Medefer as a long-term partner of the NHS.’

Board

Bruce Bower

Non-Executive Director

Bruce is a private investor based in London, with interests in technology, health and media.  He is a non-executive director of Medefer, Support Room, and Life & Soul Pictures. He helps early-stage companies with strategy, finance and fundraising.  Previously, he was a Portfolio Manager and a Partner at Verno Capital, a Russia-focused investment fund with a peak of $5 billion under management or advisory.  He began his career at Citigroup as a proprietary trader in the FX and Rates division.

Bruce is the author of “Peak Performance of Trading and Investing”.  He holds a BA from the University of Chicago and a MSc from the London School of Economics.

He has been involved with Medefer since the beginning. He loves that the company is addressing a huge unmet need for society with an innovative technological solution.

Saav Shah

Non-Executive Director

Saav is a partner at Nickleby Capital, an investment house backed by family offices and entrepreneurs.

Prior to joining Nickleby Capital, Saav ran the co-investment division of Chrystal Capital.

He advised a small group of family offices and UHNWIs, investing between £2-£15m into European private equity opportunities including Neo4J, MotoCaddy, Docplanner, Coople, Le Tote and Candid.

Saav began his career in the investment banking divisions of Rothschild, Goldman Sachs and Commerzbank.

Avril Millar

Non-Executive Director

Originally a Civil Engineer, Avril then taught Oxbridge entrance Physics and Maths for several years while her children were small before, in 1986, starting a boutique Wealth Planning business, which focussed on entrepreneurs, building it to over £500m under advice before exiting in 2007. At her exit, a client asked Avril to take over as CEO of his global banking headhunting firm, where she subsequently managed its turnaround after the 2008 crisis. Since 2009, Avril has held a number of simultaneous advisory, Non-Exec, and Interim Executive roles, typically involving businesses in high growth phases which need upskilling of the Board and senior team. Sector neutral, the businesses advised on or worked with include physical oil trading, healthcare (IVF and `resuscitation training), FX trading, deep technology, data security, investments, research, and sports. Strongly commercial, Avril specialises in helping businesses and teams grow from good to great.

‘At this stage of my long career, purpose and meaning are paramount. I am exceptionally proud and thrilled to be asked to help Medefer and its team of committed people achieve its mission to transform healthcare, support the NHS, and improve the quality of life for patients.’

Russell Wilcox

Senior Independent Director

Advisory Board

Professor Sir Mike Richards

Professor Sir Mike Richards was a hospital physician for more than 20 years. After a variety of training posts, he was a consultant medical oncologist between 1986 and 1995, and Professor of Palliative Medicine at Guy’s and St. Thomas’ Hospitals between 1995 and 1999.

In 1999 Sir Mike was appointed as the first National Cancer Director at the Department of Health. He led the development and implementation of the NHS Cancer Plan in 2000, the Cancer Reform Strategy in 2007 and Improving Outcomes: A strategy for cancer in 2011.

He became CQC’s first Chief Inspector of Hospitals in July 2013 and led the development and implementation of a new approach to hospital inspection. Sir Mike retired from this role at the end of July 2017.

Sir Mike was awarded a CBE in 2001 and appointed a Knight Bachelor in 2010

He has recently led two major reviews for NHS England: A review of adult screening services (published 2019) and a review of diagnostic services (published October 2020). This recommends a major expansion of diagnostic capacity and a new model of service delivery.

“Medefer has the potential to transform pathways to diagnosis for a very large number of patients, thereby improving patient experience and clinical outcomes.  I am delighted to be a member of the Clinical advisory Group.”

Sir Cyril Chantler

Cyril Chantler was Professor of Paediatric Nephrology and Consultant Paediatrician at Guys Hospital until 2000. He was Principal of Guy’s and St Thomas’s Hospitals Medical and Dental Schools(1992 – 1998) and Chairman of the management board of Guy’s Hospital (1985-1988). He was Chairman of Great Ormond Street Hospital (2001- 2008) and the Kings Fund (2004-2010), 

He received a knighthood for services to medicine in 1996. In January 2017 he was made a Knight Grand Cross of the Order of the British Empire (GBE) for Services to Leadership in Healthcare.

In addition, he served as a member of the Member of the NHS Policy Board (1989-1996), President of the British Association of Medical Managers (1991-1997), and as Chairman of the Council of Heads of UK Medical Schools and Faculties (1998 –1999). He was also a Member of the General Medical Council (1994–2003), where he was Chairman of the Standards Committee. He served for some years as an adviser to the Hospital Authority of Hong Kong and co-chaired the SARS expert advisory enquiry in 2003.His other previous appointments include non-executive Director of the Guy’s/Lewisham Trust (1991-92) and of the Guy’s and St Thomas’ NHS Trust (1993-97).  In addition he was Pro-Vice Chancellor, University of London (1997-2000). He was co-editor of Paediatric Nephrology from 1985 to 1996.  He served as a Member of the Council of St. George’s Medical School (2000–2003) and of the Board of Governors of London South Bank University (2002-2005).  He was Medical Director of Well Child (2001-2005), a trustee of the Dunhill Medical Trust (2001-2009) and of the British Kidney Patients Association (2007-2010). He served as Chairman of the Strategic Advisory Group for the development of Dulwich Community Hospital (2000-2005). He was Chairman of the Shared Medical Record Committee of the Care Record Development Board of Connecting for Health, and has also been involved in a number of inquiries into the provision of acute paediatric services in various parts of England. 

He was elected as an Honorary Member of the American Paediatric Society in 1991 and as a Foreign Associate of the National Academy of Medicine USA in 1999.  Cyril Chantler is a Fellow of Kings College, London, an Honorary Fellow of the Institute of Child Health London, and received an Honorary Fellowship of the Royal College of Surgeons of England in 2018 and the Royal College of Obstetricians and Gynaecologists in 2019. He has honorary degrees from London South Bank University, the University of Lille, France, the University of London, the University of Kent and University College London. He was awarded the James Spence Medal of the Royal College of Paediatrics and Child Health in 2005 and the Ira Greifer Award of the International Pediatric Nephrology Association in 2007. In 2015 he was awarded the Otto Wolff Medal by the Royal Society of Medicine. 

Sir David Dalton

Sir David has been an NHS Chief Executive for 25 years, serving at Salford Royal for 17+ years – rated ‘outstanding’ by the Care Quality Commission in each consecutive year and designated as a Global Digital Exemplar, following the creation of one of first integrated digital care records in the NHS.

He led the Northern Care Alliance, creating 5 new integrated Care Organisations in Greater Manchester.  He has a particular interest in supporting improvement and empowering staff – with a focus on patient safety.  He produced the first Quality Improvement Strategy for an NHS Trust with an explicit aim of saving lives and reducing harm.

He was knighted in 2014 for his services to Healthcare. He was a member of the ‘Berwick Review’, which advised the government on patient safety improvements and co-chaired a national review to support openness in reporting harmful events. In 2014 he led the Dalton Review which recommended actions to assure high quality healthcare was delivered through sustainable NHS organisations.

“Medefer provides the missing piece for the NHS in its search for a partner to deliver better healthcare, quicker and more reliably than it can do on its own.”